Diabetes is life long affliction that causes a person’s blood sugar level to become too high. With the two main types of diabetes, type 2 is far more common. Around 90% of all adults with diabetes have type 2.
Types
Type 2 is where the body is not creating enough insulin or the body is not reacting correctly to the insulin. This type usually requires the managing of medication, finding the right medication for each person can take time. Also many of the medications have side affects.
Type 1 is when the level of glucose in blood to be too high. This happens when the body isn’t producing enough of the hormone insulin which controls the levels of glucose in blood.
Both types are manageable with the correct advice and medication.
There are articles below that explore the condition in many different ways. Covering new research and evidence.
Afon Technology is revolutionising diabetes care with its innovative GlucowearTM – the world’s first non-invasive, real-time continuous glucose monitor. Company CEO, Sabih Chaudhry, explains how the technology is being recognised and developed.
Tess Player, VP, Global Head of Expert and Influence Marketing, GSK Consumer Healthcare, discusses how low public understanding of oral health is symptomatic of the need for better everyday health education.
Riceberry rice, enriched with a full-spectrum of antioxidants, chemoprotective compounds, micronutrients, and dietary fibre can help unlock your genetic potential for well-being, in the view of Professor Dr Apichart Vanavichit, Director at the Rice Science Center in Thailand.
Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, argues that the rice crop is a vital cog in ensuring food security
Isabelle Ote and Valérie Barette, Project Leaders at Belgian immunotherapy expert Imcyse, discuss its next phase of growth, and how to apply ImotopeTM technology to the treatment of MS.
Professor Andrew Boulton, President & Professor Akhtar Hussain, President-Elect of the International Diabetes Federation, argue that while there has been a century of saving lives, more must be done to tackle diabetes.
Dr Faz Chowdhury, CEO at Nemaura Medical (Nasdaq: NMRD), aims to stem the tide of the onset of diabetes and help to manage and reverse Type 2 diabetes using the world’s first daily-wear non-invasive CGM technology.
The idea is still at an early stage, but initial clinical study results show that immunotherapy against type 1 diabetes could function as a 'diabetes vaccine.'
Gary Davies, from Sandvik Materials Technology, explains how medical wires are helping patients monitor blood glucose levels without the need for daily testing.
